Evidence map›Paper›PMID 35039595›Full record

Trial reportScientific reports2022

Neuronally-enriched exosomal microRNA-27b mediates acute effects of ibuprofen on reward-related brain activity in healthy adults: a randomized, placebo-controlled, double-blind trial.

Kaiping Burrows, Leandra K Figueroa-Hall, Rayus Kuplicki, Jennifer L Stewart, Ahlam M Alarbi, Rajagopal Ramesh, Jonathan B Savitz, T Kent Teague, Victoria B Risbrough, Martin P Paulus

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kaiping BurrowsLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA. kburrows@laureateinstitute.org.
Leandra K Figueroa-HallLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Rayus KuplickiLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Jennifer L StewartLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Ahlam M AlarbiDepartments of Surgery and Psychiatry, School of Community Medicine, The University of Oklahoma, Tulsa, OK, USA.
Rajagopal RameshDepartment of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Jonathan B SavitzLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
T Kent TeagueDepartments of Surgery and Psychiatry, School of Community Medicine, The University of Oklahoma, Tulsa, OK, USA.
Victoria B RisbroughCenter of Excellence for Stress and Mental Health, La Jolla, CA, USA.
Martin P PaulusLaureate Institute for Brain Research, 6655 South Yale Ave, Tulsa, OK, 74136, USA.
Laureate Institute for Brain Research · USUniversity of Oklahoma · USUniversity of California, San Diego · USUniversity of Oklahoma Health Sciences Center · USUniversity of Tulsa · US

Funding

The Center for Neuroscience-based Mental Health Assessment and Prediction (NEUROMAP)P20GM121312 · NIGMS · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI ROBIN L AUPPERLE · 2017 to 2026
$23.7M
Plasticity of Aversive Salience in Opioid Use DisorderR01DA050677 · NIDA · LAUREATE INSTITUTE FOR BRAIN RESEARCH · PI STEWART, JENNIFER LORRAINE · 2021 to 2025
$3.0M
Neuronal exosomes to identify biomarkers and pathology of deployment-related TBII01BX004312 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI RISBROUGH, VICTORIA B, RISSMAN, ROBERT · 2019 to 2022
–
BLRD VA I01 BX004312CSRD VA IK2 CX002343NIDA NIH HHS R01 DA050677NIGMS NIH HHS P20 GM121312NIGMS NIH HHS P20GM121312
6 · The paper itself

Abstract

This double-blind, randomized, within-subjects design evaluated whether acute administration of an anti-inflammatory drug modulates neuron-specific, inflammation-modulating microRNAs linked to macroscopic changes in reward processing. Twenty healthy subjects (10 females, 10 males) underwent a functional magnetic resonance imaging scan while performing a monetary incentive delay (MID) task and provided blood samples after administration of placebo, 200 mg, or 600 mg of ibuprofen. Neuronally-enriched exosomal microRNAs were extracted from serum and sequenced. Results showed that: (1) 600 mg of ibuprofen exhibited higher miR-27b-3p, miR-320b, miR-23b and miR-203a-3p expression than placebo; (2) higher mir-27b-3p was associated with lower insula activation during MID loss anticipation; and (3) there was an inverse relationship between miR-27b-3p and MID gain anticipation in bilateral putamen during placebo, a pattern attenuated by both 200 mg and 600 mg of ibuprofen. These findings are consistent with the hypothesis that miR-27b could be an important messaging molecule that is associated with regulating the processing of positive or negative valenced information.

Indexed as

RewardBrainDose-Response Relationship, DrugDouble-Blind MethodFemaleGene ExpressionHealthy VolunteersHumansIbuprofenMagnetic Resonance ImagingMaleMental ProcessesMicroRNAsMotivationPlacebo EffectIbuprofenMicroRNAsMIRN27b microRNA, human

Identifiers

PMID35039595
PMCPMC8764091
OpenAlexW4206063797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.